Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000950170-25-002866·Actyus Private Equity SGIIC, S.A.
Schedule 13G ownership disclosure
Elicio Therapeutics, Inc.
Common Stock, par value $0.01 per share · CUSIP: 28657F103
Event date: 2023-12-08
- Filing-level shares
- 587,818
- Percent of class
- 5.45%
- Actyus Private Equity SGIIC, S.A.
Shares: 587,818 · Class: 5.45%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-002866
- Form type
- SCHEDULE 13G
- Filer
- Actyus Private Equity SGIIC, S.A.
- CIK
- CIK 2050492
- Filed
- Jan 07, 2025
- Reporting period
- Dec 08, 2023
- Description
- Schedule 13G beneficial ownership